SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

Synaptic Plasticity Therapeutics for Parkinson's Disease

active
wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-synaptic-plasticity-th
Related Entities
therapeutics-synaptic-plasticity-therapeutics-pd
🌍 Provenance Graph 8 nodes, 29 edges

cites (1)

derives from (6)

▸ Show 1 more

supports (3)

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
296
Outgoing
363
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (459)
mentions🔬Analysis question not specified100%
mentions🔬Analysis question not specified100%
mentions🔬Sleep disruption as cause and consequence of neurodegenerati100%
mentions🔬Why do entorhinal cortex layer II stellate neurons die first100%
mentions🔬Can speech, gait, retinal imaging, sleep, and smartphone dat100%
mentions🧪Epigenetic Memory Reprogramming for Alzheimer's Disease90%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease81%
cites📄Assessment of the Spatial Distribution of Moisture Content i80%
supports🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho75%
supports🧪SASP-Driven Aquaporin-4 Dysregulation75%
supports🧪FOXO3-Longevity Pathway Epigenetic Reprogramming75%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation70%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧪SASP-Mediated Cholinergic Synapse Disruption70%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers70%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation70%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%
mentions🧪Complement-Mediated Synaptic Pruning Dysregulation70%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption70%
related🧪Complement C1QA Spatial Gradient in Cortical Layers70%
mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation70%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation70%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%
mentions🧪Vagal Afferent Microbial Signal Modulation68%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming67%
related🧪SASP-Driven Aquaporin-4 Dysregulation67%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho67%
related🧪Complement-Mediated Synaptic Pruning Dysregulation63%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement63%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%
mentions🧪Vocal Cord Neuroplasticity Stimulation63%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna62%
related🧪Vagal Afferent Microbial Signal Modulation61%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🔬What are the mechanisms underlying synaptic pruning by micro60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
see_also📖LRRK2 G2019S Transgenic Mouse Model60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
see_also📖APOB Gene60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Cytochrome Therapeutics60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🔬Investigate how lipid raft composition (cholesterol metaboli60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
see_also📖MCL1 Gene - Myeloid Cell Leukemia 160%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
see_also📖entities-gba160%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
see_also📖CNTNAP4 Gene60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
see_also📖DOT1L Gene60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
see_also📖eef1a160%
see_also📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
see_also📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
see_also📖IDH1 Gene - Isocitrate Dehydrogenase 160%
related🧪Vocal Cord Neuroplasticity Stimulation56%
see_also📖Pericyte Loss in Neurodegeneration55%
see_also📖Exosomal miR-155 in Neurodegeneration55%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration55%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 55%
see_also📖Metabolomic Biomarkers in Neurodegeneration55%
see_also📖NRF2 Signaling Pathway in Neurodegeneration55%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration55%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration55%
see_also📖Prion Diseases in Neurodegeneration55%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration55%
see_also📖Ribosome Dysfunction in Neurodegeneration55%
see_also📖HMGB1 Signaling in Neurodegeneration55%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati55%
see_also📖FA2H-Associated Neurodegeneration Pathway55%
see_also📖Histone Modification Pathways in Neurodegeneration55%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration55%
see_also📖Microglial Priming Pathway in Neurodegeneration55%
see_also📖Amylin Signaling in Neurodegeneration55%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 55%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat55%
see_also📖India Neurodegeneration Epidemiology55%
see_also📖Dystrophic Neurites in Neurodegeneration55%
see_also📖European Neurodegeneration Epidemiology55%
see_also📖Cholinergic System Dysfunction in Neurodegeneration55%
see_also📖interleukin-6-signaling-neurodegeneration55%
see_also📖IL-1 Signaling Pathway in Neurodegeneration55%
see_also📖Prion Protein Metabolism in Neurodegeneration55%
see_also📖Purinergic Signaling in Neurodegeneration55%
see_also📖Metal Homeostasis in Neurodegeneration55%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)55%
see_also📖Protein Aggregation Comparison in Neurodegeneration55%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration55%
see_also📖Neural Circuit Disruption in Neurodegeneration55%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration55%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration55%
see_also📖CaMKII Signaling Pathway in Neurodegeneration55%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade55%
see_also📖RNA-Targeted Therapies in Neurodegeneration55%
see_also📖Economic Burden — Neurodegeneration55%
see_also📖PKR Pathway in Neurodegeneration55%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen55%
see_also📖Sleep Dysfunction in Neurodegeneration55%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration55%
see_also📖Neuropil Threads in Neurodegeneration55%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 55%
see_also📖Global Neurodegeneration Epidemiology55%
see_also📖synaptic-vesicle-cycling-neurodegeneration55%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration55%
see_also📖epigenetics-neurodegeneration55%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration55%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)55%
see_also📖Serotonergic Dysfunction in Neurodegeneration55%
see_also📖RNA Splicing in Neurodegeneration55%
see_also📖mTOR Signaling in Neurodegeneration55%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration55%
see_also📖PPAR Signaling Pathway in Neurodegeneration55%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration55%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration55%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration55%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration55%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener55%
see_also📖Senescent Cell Clearance in Neurodegeneration55%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a55%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration55%
see_also📖Potential Impact Measures — Neurodegeneration55%
see_also📖Neural Circuits in Neurodegeneration55%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain55%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration55%
see_also📖DALY Methodology — Neurodegeneration55%
see_also📖Lipid Dysregulation in Neurodegeneration55%
see_also📖Axon Guidance Pathways in Neurodegeneration55%
see_also📖MicroRNA Dysfunction in Neurodegeneration55%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration55%
see_also📖Mitochondrial Fusion in Neurodegeneration55%
see_also📖Endothelin Signaling Pathway in Neurodegeneration55%
see_also📖Vagus Nerve Pathway in Neurodegeneration55%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration55%
see_also📖Synaptic Biomarkers in Neurodegeneration55%
see_also📖Advanced Glycation End Products in Neurodegeneration55%
see_also📖Neuropeptide Y Signaling in Neurodegeneration55%
see_also📖Parthanatos in Neurodegeneration55%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration55%
see_also📖Prion-Like Spread in Neurodegeneration55%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su55%
see_also📖US Neurodegeneration Epidemiology55%
see_also📖Retinal Degeneration Pathway in Neurodegeneration55%
see_also📖Prognostic Biomarkers in Neurodegeneration55%
see_also📖Nitric Oxide Signaling in Neurodegeneration55%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 55%
see_also📖Hippocampal Neurogenesis in Neurodegeneration55%
see_also📖COVID-19 Neurodegeneration Mechanism55%
see_also📖Liquid Biopsy in Neurodegeneration55%
see_also📖Down Syndrome Neurodegeneration Pathway55%
see_also📖T-Cell Dysfunction in Neurodegeneration55%
see_also📖Therapeutic Targets in Neurodegeneration55%
see_also📖Japan Neurodegeneration Epidemiology55%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration55%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration55%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration55%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration55%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration55%
see_also📖Sleep Disorders in Neurodegeneration55%
see_also📖Orexin Signaling in Neurodegeneration55%
see_also📖Protein Aggregation Seeds in Neurodegeneration55%
see_also📖Paranodal Dysfunction in Neurodegeneration55%
see_also📖Neurotensin Signaling in Neurodegeneration55%
see_also📖Endocannabinoid System in Neurodegeneration55%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration55%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration55%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N55%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration55%
see_also📖Short Chain Fatty Acids in Neurodegeneration55%
see_also📖RAN Translation in Neurodegeneration55%
see_also📖Paraptosis in Neurodegeneration55%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration55%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration55%
see_also📖Disease Progression & Staging in Neurodegeneration55%
see_also📖Convergent Pathways in Neurodegeneration55%
see_also📖Neuroimaging Biomarkers for Neurodegeneration55%
see_also📖Endosomal Sorting Defects in Neurodegeneration55%
see_also📖Glycosylation in Neurodegeneration55%
mentions🧪Smartphone-Detected Motor Variability Correction55%
see_also📖Neuronal Hyperexcitability in Neurodegeneration55%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration55%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)55%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration55%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison55%
see_also📖Copper Homeostasis in Neurodegeneration55%
see_also📖SUMOylation in Neurodegeneration55%
see_also📖R-Loop Stress in Neurodegeneration55%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio55%
see_also📖acetylcholine-signaling-neurodegeneration55%
see_also📖Computational Disease Models for Neurodegeneration55%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration55%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio55%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration55%
see_also📖Familial vs Sporadic Neurodegeneration Comparison55%
see_also📖Diffusion MRI (DTI) in Neurodegeneration55%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration55%
see_also📖China Neurodegeneration Epidemiology55%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration55%
see_also📖Molecular Chaperones in Neurodegeneration55%
see_also📖Autosis Pathway in Neurodegeneration55%
see_also📖Manganese-Related Neurodegeneration (Manganism)55%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)55%
see_also📖Antibody Therapy in Neurodegeneration55%
see_also📖Integrated Stress Response in Neurodegeneration55%
see_also📖GDNF Signaling Pathway in Neurodegeneration55%
see_also📖mTOR Signaling Pathway in Neurodegeneration55%
see_also📖Digital Phenotyping in Neurodegeneration55%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl55%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration55%
see_also📖Gangliosides in Neurodegeneration55%
see_also📖Galectin-3 Mechanism in Neurodegeneration55%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread55%
see_also📖Kidney-Brain Neurodegeneration Axis55%
see_also📖Exosomal Biomarkers in Neurodegeneration55%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)55%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration55%
see_also📖Sex Differences in Neurodegeneration55%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr55%
see_also📖NF-kB Signaling Pathway in Neurodegeneration55%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration55%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and55%
see_also📖Progesterone Signaling Pathway in Neurodegeneration55%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Cytochrome Therapeutics54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
mentions🧪Complement C1q Subtype Switching50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
related🔬What are the most promising therapeutic strategies for targe50%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
see_also📖Master Screening Study to Determine Individuals With Potenti50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬Investigate prion-like spreading of tau pathology through co50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬Synaptic pruning by microglia in early AD50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%
mentions🧫Dexamethasone treatment study in α-synuclein mice50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime50%
related🔬What are the mechanisms underlying selective vulnerability o50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St50%
mentions🧫TLR expression in α-synuclein overexpressing mice50%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%
mentions🧪Microbial Inflammasome Priming Prevention50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease45%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'45%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer45%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease45%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway45%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A45%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's45%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer45%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa45%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 45%
see_also📖Endolysosomal Pathway in Alzheimer's Disease45%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial45%
see_also📖Sporadic Alzheimer's Disease Pathway45%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise45%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial45%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ45%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC45%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t45%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di45%
mentions🧫Acteoside effects on RAW264.7 macrophage cells44%
mentions🧫Functional analysis of EFNB1-EPHB4 interaction in EMT44%
mentions🧫Leukocyte gene expression analysis in COVID-19 patients44%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro44%
mentions🧫s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice 44%
mentions🧫Nrf2 inhibitor ML385 mechanism validation experiment44%
mentions🧫Spatial transcriptomic analysis of multistage ESCC developme44%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model44%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise44%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne44%
mentions🧫Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr44%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD44%
mentions🧫Acteoside treatment in LPS-induced SALI mouse model44%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%
mentions🔬Synaptic pruning by microglia in early AD40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
related🧪Synaptic Vesicle Tau Capture Inhibition40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬Investigate prion-like spreading of tau pathology through co40%
related🧪Trans-Synaptic Adhesion Molecule Modulation40%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics40%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu35%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics35%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement35%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination35%
related🧪Complement-Mediated Synaptic Pruning Dysregulation35%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna35%
related🧪Synaptic Vesicle Tau Capture Inhibition35%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization35%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub